|
Q1 FY2025
As of Oct 31, 2024
|
Q4 FY2024
As of Jul 31, 2024
|
Q3 FY2024
As of Apr 30, 2024
|
Q2 FY2024
As of Jan 31, 2024
|
Q1 FY2024
As of Oct 31, 2023
|
Q4 FY2023
As of Jul 31, 2023
|
Q3 FY2023
As of Apr 30, 2023
|
Q2 FY2023
As of Jan 31, 2023
|
Q1 FY2023
As of Oct 31, 2022
|
Q4 FY2022
As of Jul 31, 2022
|
Q3 FY2022
As of Apr 30, 2022
|
Q2 FY2022
As of Jan 31, 2022
|
Q1 FY2022
As of Oct 31, 2021
|
Q4 FY2021
As of Jul 31, 2021
|
Q3 FY2021
As of Apr 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||
| Current assets: | |||||||||||||||
| Cash | |||||||||||||||
| Accounts receivable trade, net | |||||||||||||||
| Due from related party | |||||||||||||||
| Inventories | |||||||||||||||
| Prepaid expenses and other current assets | |||||||||||||||
| Total current assets | |||||||||||||||
| Property and equipment, net | |||||||||||||||
| Operating lease right-of-use assets | |||||||||||||||
| Intangible assets, net | |||||||||||||||
| Goodwill | |||||||||||||||
| Other assets | |||||||||||||||
| Total long-term assets | |||||||||||||||
| Total assets | |||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||||||
| Current liabilities: | |||||||||||||||
| Accounts payable | |||||||||||||||
| Accrued expenses | |||||||||||||||
| Accrued compensation | |||||||||||||||
| Nonrelated Party | |||||||||||||||
| Related Party | |||||||||||||||
| Total accrued compensation | |||||||||||||||
| Current operating lease liabilities | |||||||||||||||
| Deferred revenue | |||||||||||||||
| Current maturities of long-term debt | |||||||||||||||
| Other current liabilities | |||||||||||||||
| Total current liabilities | |||||||||||||||
| Revolving line of credit | |||||||||||||||
| Long-term debt, net of current maturities and debt issuance costs | |||||||||||||||
| Operating lease liabilities | |||||||||||||||
| Derivative instrument | |||||||||||||||
| Deferred income taxes | |||||||||||||||
| Other liabilities | |||||||||||||||
| Total long-term liabilities | |||||||||||||||
| Total liabilities | |||||||||||||||
| Stockholders’ equity: | |||||||||||||||
| Common stock, $0.01 par value; 500,000,000 shares authorized; 147,200,572 and 147,073,614 issued and outstanding at October 31, 2024 and July 31, 2024, respectively | |||||||||||||||
| Additional paid-in capital | |||||||||||||||
| Retained earnings | |||||||||||||||
| Total The Duckhorn Portfolio, Inc. stockholders’ equity | |||||||||||||||
| Non-controlling interest | |||||||||||||||
| Total stockholders’ equity | |||||||||||||||
| Total liabilities and stockholders’ equity | |||||||||||||||
| Common stock, par value (in dollars per share) | |||||||||||||||
| Common stock, shares issued (in shares) | |||||||||||||||
| Common stock, shares outstanding (in shares) | |||||||||||||||
Loading...
